On October 6, 2021, the Court of Justice of the European Union (“CJEU”) ruled in the second Boehringer case with respect to the reduction of the taxable amounts resulting from rebates granted to public health insurers.
The CJEU ruled that pharmaceutical companies are allowed to reduce their taxable amount when voluntary rebates are granted to public health insurers and that administrative obligations to claim this reduction imposed by Member States must be limited.
Source Deloitte
Latest Posts in "European Union"
- VAT Neutrality and Tax Fraud: Implications of Recent Jurisprudence
- Blog Luc Dhont: How Can Multinationals Comply with VAT on Transfer Pricing Adjustments Post-ECJ Arcomet?
- ECJ Opinion Sheds Light on VAT for Ancillary Services in German Accommodation Sector
- Briefing document & Podcast – C-409/04 (Teleos): Physical Movement & Supplier Due Diligence Key for Intra-EU VAT Exemption
- EU boosts tax cooperation with Andorra, Liechtenstein, Monaco, and San Marino